- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Shenzhen Hepalink Pharmaceutical (9989)
Shenzhen Hepalink Pharmaceutical stock price live, this page displays HK 9989 stock exchange data. View the 9989 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Shenzhen Hepalink Pharmaceutical real time stock price chart below.
What Is the Shenzhen Hepalink Pharmaceutical Stock Price Today?
The Shenzhen Hepalink Pharmaceutical stock price today is 4.57.
What Is the Stock Symbol for Shenzhen Hepalink Pharmaceutical ?
The stock symbol for Shenzhen Hepalink Pharmaceutical is "9989."
What Stock Exchange Does Shenzhen Hepalink Pharmaceutical Trade On?
Shenzhen Hepalink Pharmaceutical is listed and trades on the Hong Kong stock exchange.
Is Shenzhen Hepalink Pharmaceutical a Good Stock to Buy?
Determining whether Shenzhen Hepalink Pharmaceutical —or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 9989 quote. (ISIN: CNE100003YN2)
What Is the Shenzhen Hepalink Pharmaceutical Stock Price Today?
The Shenzhen Hepalink Pharmaceutical stock price today is 4.57.
What Is the Stock Symbol for Shenzhen Hepalink Pharmaceutical ?
The stock symbol for Shenzhen Hepalink Pharmaceutical is "9989."
What Stock Exchange Does Shenzhen Hepalink Pharmaceutical Trade On?
Shenzhen Hepalink Pharmaceutical is listed and trades on the Hong Kong stock exchange.
Is Shenzhen Hepalink Pharmaceutical a Good Stock to Buy?
Determining whether Shenzhen Hepalink Pharmaceutical —or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 9989 quote. (ISIN: CNE100003YN2)
4.57
+0.11(+2.47%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.41
4.57
52 wk Range
2.63
5.92
9989 Scorecard
Full Analysis
High shareholder yield
Earnings results expected in 5 days
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.414.57
52 wk Range
2.635.92
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
9989 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
3.73
Downside
-18.28%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Shenzhen Hepalink Pharmaceutical Company Profile
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. The company operates through four segments: Finished Dose Pharmaceutical Products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization, and Others. Its pharmaceutical products consist of finished dose pharmaceutical products, which primarily include enoxaparin sodium injection; API products, including heparin sodium API and enoxaparin sodium API; and other products, such as pancreatin API. The company is also involved in the provision of research and development, manufacturing, quality management, and program management services; and development and manufacture of recombinant pharmaceutical products, critical non-viral vectors, intermediates for gene therapy, and naturally derived pharmaceutical products. In addition, it engages in research, development, production, services, and trading biopharmaceutical; property management, investment management and consulting, biopharmaceutical technology development and consulting, and equity and venture investment activities; production and sale of heparin sodium; provision of services on pharmaceutical related activities; and trading of medical and biopharmaceutical products. The company was formerly known as Shenzhen Hepalink Pharmaceutical Co.,Ltd. and changed its name to Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in February 2017. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. was founded in 1998 and is headquartered in Shenzhen, the People’s Republic of China.
Compare 9989 to Peers and Sector
Metrics to compare | 9989 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship9989PeersSector | |
|---|---|---|---|---|
P/E Ratio | −100.2x | −20.2x | −0.5x | |
PEG Ratio | 0.60 | 0.03 | 0.00 | |
Price/Book | 1.2x | 2.3x | 2.6x | |
Price / LTM Sales | 2.7x | 5.3x | 3.0x | |
Upside (Analyst Target) | −18.3% | 62.9% | 55.2% | |
Fair Value Upside | Unlock | −12.7% | 9.7% | Unlock |
Analyst Ratings
0 Buy
1 Hold
1 Sell
Ratings:
2 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 3.73
(-18.28% Downside)
Earnings
Latest Release
Oct 30, 2024
EPS / Forecast
0.0868 / 0.0768
Revenue / Forecast
1.35B / 1.40B
FAQ
What Is the Shenzhen Hepalink (9989) Stock Price Today?
The Shenzhen Hepalink stock price today is 4.57
What Stock Exchange Does Shenzhen Hepalink Trade On?
Shenzhen Hepalink is listed and trades on the Hong Kong stock exchange.
What Is the Stock Symbol for Shenzhen Hepalink?
The stock symbol for Shenzhen Hepalink is "9989."
What Is the Shenzhen Hepalink Market Cap?
As of today, Shenzhen Hepalink market cap is 15.72B.
What is Shenzhen Hepalink Earnings Per Share?
The Shenzhen Hepalink EPS is -0.10.
What Is the Next Shenzhen Hepalink Earnings Date?
Shenzhen Hepalink will release its next earnings report on 27 Mar 2025.
From a Technical Analysis Perspective, Is 9989 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.